Section Arrow
ACOG.NASDAQ
- Alpha Cognition Inc
Quotes are at least 15-min delayed:2025/11/04 07:40 EST
Pre Market
Last
 6.57
+0.87 (+15.26%)
Bid
5.6
Ask
6.59
High 6.74 
Low 6.49 
Volume 245 
Regular Hours
Last
 5.7
-0.49 (-7.92%)
Day High 
6.245 
Prev. Close
6.19 
1-M High
7.8392 
Volume 
155.21K 
Bid
5.6
Ask
6.59
Day Low
5.65 
Open
6.13 
1-M Low
5.905 
Market Cap 
129.38M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 6.7 
20-SMA 6.96 
50-SMA 7.75 
52-W High 11.54 
52-W Low 3.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.59/-1.66
Enterprise Value
129.38M
Balance Sheet
Book Value Per Share
1.53
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PHIOPhio Pharmaceuticals Corp1.86-0.19-9.27%0.01PE
Pre Market 1.69 -0.17 -9.14%
CRBUCaribou Biosciences2.43+0.01+0.41%-- 
Pre Market 2.42 -0.01 -0.41%
IOVAIovance Biotherapeutics1.95-0.02-1.02%-- 
Pre Market 1.91 -0.04 -2.05%
RXRXRecursion Pharmaceuticals5.44-0.08-1.45%-- 
Pre Market 5.25 -0.19 -3.49%
THARTharimmune Inc.3.2+0.25+8.47%0.03PE
Pre Market 3.01 -0.19 -5.94%
Quotes are at least 15-min delayed:2025/11/04 07:40 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.